GILD - GILEAD SCIENCES, INC.
96.91
-1.250 -1.290%
Share volume: 13,008,987
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$98.16
-1.25
-0.01%
Summary score
90%
Profitability
100%
Dept financing
50%
Liquidity
53%
Performance
100%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
16.07%
Return on assets
7.46%
Return on sales
59.59%
Return on invested capital
13.06%
Total debt ratio
65.75%
Debt ratio change over timeo
0%
Current Ratio
2.59%
Quick Ratio
2.43%
Cash Position Ratio
0.98%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
13.54%
Return on assets
6.63%
Return on sales
57.77%
Return on invested capital
12.01%
Total debt ratio
63.84%
Debt ratio change over timeo
0%
Current Ratio
2.96%
Quick Ratio
2.8%
Cash Position Ratio
1.09%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
10.94%
Return on assets
5.94%
Return on sales
58.7%
Return on invested capital
13.76%
Total debt ratio
61.58%
Debt ratio change over time
0%
Current Ratio
3.68%
Quick Ratio
3.56%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GILD | AMGN | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 16.07% | 6.52% | 0% | 8% |
| Return on assets | 7.46% | 3.2% | 0% | 5.12% |
| Return on sales | 59.59% | 44.03% | 0% | 42.46% |
| Return on invested capital | 13.06% | 9.05% | 0% | 8.23% |
| Profitability | 100% | 57% | 0% | 63% |
| Total debt ratio | 65.75% | 60.67% | 0% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 23% | 0% | 18% |
| Current Ratio | 2.96% | 5.2% | 0% | 2.29% |
| Quick Ratio | 2.8% | 4.88% | 0% | 1.99% |
| Cash Position Ratio | 1.09% | 0.33% | 0% | 0.45% |
| Liquididy | 52% | 58% | 0% | 38% |
| Short-term ratios | GILD | AMGN | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 13.54% | 6.57% | 0% | 7.21% |
| Return on assets | 6.63% | 3.23% | 0% | 5.05% |
| Return on sales | 57.77% | 44.59% | 0% | 41.29% |
| Return on invested capital | 12.01% | 9.41% | 0% | 7.62% |
| Profitability | 100% | 63% | 0% | 66% |
| Total debt ratio | 63.84% | 60.55% | 0% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 24% | 0% | 18% |
| Current Ratio | 2.96% | 5.2% | 0% | 2.29% |
| Quick Ratio | 2.8% | 4.88% | 0% | 1.99% |
| Cash Position Ratio | 1.09% | 0.33% | 0% | 0.45% |
| Liquididy | 54% | 58% | 0% | 32% |
